Akkadian Partners Fund
Overview
Akkadian Partners Fund is a Luxembourg-based private equity fund specializing in healthcare investments. The fund focuses on sectors such as biotechnology, pharmaceuticals, medical devices, healthcare services, and healthcare IT. It targets companies at growth, late stage, and pre-IPO stages, primarily in Luxembourg, France, Germany, the United Kingdom, and the United States. The fund's investment size ranges from $1 million to $50 million. Akkadian Partners Fund is managed by Akkadian Partners S.A., located at 18 rue Robert Stümper, Luxembourg. The fund's Legal Entity Identifier (LEI) is 984500DE0D0714B3C747, and it is registered under the jurisdiction of Luxembourg. The fund was established on July 28, 2021, and is currently active. Akkadian Partners Fund has a track record of investments in various healthcare companies, demonstrating its commitment to advancing the healthcare sector through strategic investments. The fund's investment philosophy emphasizes creating value by supporting companies that contribute to the improvement of healthcare services and products. By leveraging its expertise and resources, Akkadian Partners Fund aims to foster innovation and growth within the healthcare industry, aligning with its mission to enhance global health outcomes through targeted investments.
Investment Focus
- Companies in the healthcare sector
- Growth, late stage, or pre-IPO companies
- Companies located in Luxembourg, France, Germany, United Kingdom, or United States
- Investment sizes between $1 million and $50 million
Portfolio Companies
Reach Akkadian Partners Fund directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Akkadian Partners Fund
What sectors does Akkadian Partners Fund invest in?
Akkadian Partners Fund invests in Healthcare, Healthcare Services, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Luxembourg. Akkadian Partners Fund is listed as a private equity in the ConnectSafely investor database.
What stage does Akkadian Partners Fund invest at?
Akkadian Partners Fund backs companies at Growth, Late Stage and Pre-IPO, writing cheques of 1M - 50M.
Which regions does Akkadian Partners Fund invest in?
Akkadian Partners Fund invests across United States, United Kingdom, Germany, France and Luxembourg.
What companies has Akkadian Partners Fund invested in?
Akkadian Partners Fund's portfolio includes Erytech Pharma, OncoOne, Nanobiotix, Genfit, Carbios, Theraclion, Biocartis and Medincell.
Last updated · Source: ConnectSafely investor database
